TVTX logo

Travere Therapeutics (TVTX) Short Term Debt

Annual Short Term Debt

$74.08 M
+$69.17 M+1409.13%

December 31, 2024


Summary


Performance

TVTX Short Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTVTXbalance sheetmetrics:

Quarterly Short Term Debt

$74.08 M
+$187.00 K+0.25%

December 1, 2024


Summary


Performance

TVTX Quarterly Short Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTVTXbalance sheetmetrics:

Short Term Debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

TVTX Short Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+1409.1%+1409.1%
3 y3 years+1795.7%+1409.1%
5 y5 years-+1409.1%

TVTX Short Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+1795.7%at high+1795.7%
5 y5-yearat high>+9999.0%at high>+9999.0%
alltimeall timeat high>+9999.0%at high-100.0%

Travere Therapeutics Short Term Debt History

DateAnnualQuarterly
Dec 2024
$74.08 M(+1409.1%)
-
Dec 2024
-
$74.08 M(+0.3%)
Sep 2024
-
$73.90 M(+1331.3%)
Jun 2024
-
$5.16 M(+2.5%)
Mar 2024
-
$5.04 M(+2.6%)
Dec 2023
$4.91 M(+10.7%)
$4.91 M(+2.7%)
Sep 2023
-
$4.78 M(+2.6%)
Jun 2023
-
$4.66 M(+2.6%)
Mar 2023
-
$4.54 M(+2.5%)
Dec 2022
$4.43 M(+13.4%)
$4.43 M(+4.7%)
Sep 2022
-
$4.23 M(+2.7%)
Jun 2022
-
$4.12 M(+2.7%)
Mar 2022
-
$4.01 M(+2.7%)
Dec 2021
$3.91 M(+994.7%)
$3.91 M(+994.7%)
Dec 2020
$357.00 K(-98.4%)
$357.00 K(-98.4%)
Mar 2019
-
$22.54 M(+0.4%)
DateAnnualQuarterly
Dec 2018
$22.46 M(-44.5%)
$22.46 M(+0.4%)
Sep 2018
-
$22.38 M(-50.7%)
Jun 2018
-
$45.40 M(>+9900.0%)
Sep 2015
-
$0.00(-100.0%)
Jun 2015
-
$41.13 M(>+9900.0%)
Mar 2015
-
$0.00(-100.0%)
Dec 2014
$40.49 M(+4475.7%)
$40.49 M(+29.4%)
Mar 2014
-
$31.28 M(>+9900.0%)
Dec 2012
$884.80 K(+3439.2%)
-
Nov 2012
-
$25.00 K(0.0%)
Aug 2012
-
$25.00 K(0.0%)
May 2012
-
$25.00 K(0.0%)
Feb 2012
-
$25.00 K(0.0%)
Feb 2012
$25.00 K(0.0%)
-
Nov 2011
-
$25.00 K(0.0%)
Feb 2011
$25.00 K
$25.00 K

FAQ

  • What is Travere Therapeutics annual short term debt?
  • What is the all time high annual short term debt for Travere Therapeutics?
  • What is Travere Therapeutics annual short term debt year-on-year change?
  • What is Travere Therapeutics quarterly short term debt?
  • What is the all time high quarterly short term debt for Travere Therapeutics?
  • What is Travere Therapeutics quarterly short term debt year-on-year change?

What is Travere Therapeutics annual short term debt?

The current annual short term debt of TVTX is $74.08 M

What is the all time high annual short term debt for Travere Therapeutics?

Travere Therapeutics all-time high annual short term debt is $74.08 M

What is Travere Therapeutics annual short term debt year-on-year change?

Over the past year, TVTX annual short term debt has changed by +$69.17 M (+1409.13%)

What is Travere Therapeutics quarterly short term debt?

The current quarterly short term debt of TVTX is $74.08 M

What is the all time high quarterly short term debt for Travere Therapeutics?

Travere Therapeutics all-time high quarterly short term debt is $74.08 M

What is Travere Therapeutics quarterly short term debt year-on-year change?

Over the past year, TVTX quarterly short term debt has changed by +$69.17 M (+1409.13%)